Dr. Zalzala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
835 Mason St
Ste A250
Dearborn, MI 48124Phone+1 313-355-8657Fax+1 888-655-7536
Education & Training
- Wayne State University School of MedicineResidency, Family Medicine, 2009 - 2012
- Wayne State University School of MedicineClass of 2009
Certifications & Licensure
- MI State Medical License 2011 - 2027
- DC State Medical License 2019 - 2027
- HI State Medical License 2017 - 2026
- OK State Medical License 2018 - 2026
- PA State Medical License 2016 - 2026
- RI State Medical License 2018 - 2026
- NY State Medical License 2017 - 2026
- American Board of Family Medicine Family Medicine
- Join now to see all
Clinical Trials
- Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study Start of enrollment: 2020 Jan 01
Publications & Presentations
PubMed
- Evaluation of off-label rapamycin use on oral health.Johnny Hudson, Tammi Kaeberlein, Akashdeep Mahal, Nelson Wong, Mina Ghorbanifarajzadeh
Geroscience. 2024-10-01 - 1 citationsThe role of quality of life data as an endpoint for collecting real-world evidence within geroscience clinical trials.Girish Harinath, Sajad Zalzala, Andy Nyquist, Maartje Wouters, Anar Isman
Ageing Research Reviews. 2024-06-01 - 7 citationsLow-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19.Anar Isman, Andy Nyquist, Bailey Strecker, Girish Harinath, Virginia Lee
Brain, Behavior, & Immunity - Health. 2024-03-01
Journal Articles
- A Novel Approach to Boosting Glutathione via IontophoresisSajad Zalzala, Cureus, 9/7/2021
Press Mentions
- Why Anti-Aging Clinics Are Going MainstreamJune 25th, 2020
- Low Dose Naltrexone and More | Podcast #185May 9th, 2018
- People Say Weight-Loss Drugs 'Stop Working' — Here's What We Know About the 'Ozempic Plateau' and How to Avoid ItDecember 17th, 2023
Professional Memberships
- American Telemedicine AssociationMember
External Links
- LinkedIn https://www.linkedin.com/in/szalzala
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: